PUBLICATION
The construction of intrahepatic cholangiocarcinoma model in zebrafish
- Authors
- Wang, J., Leng, X., Wang, G., Wan, X., Cao, H.
- ID
- ZDB-PUB-171019-7
- Date
- 2017
- Source
- Scientific Reports 7: 13419 (Journal)
- Registered Authors
- Cao, Hong, Wang, Gui-Ping, Wang, Jing, Wan, Xiaoyang
- Keywords
- none
- MeSH Terms
-
- Animals
- Bile Duct Neoplasms/genetics*
- Bile Duct Neoplasms/pathology
- Biomarkers, Tumor/genetics*
- Biomarkers, Tumor/metabolism
- Cholangiocarcinoma/genetics*
- Cholangiocarcinoma/pathology
- DNA Methylation
- Disease Models, Animal
- Liver/metabolism
- Transcriptome
- Zebrafish
- Zebrafish Proteins/genetics*
- Zebrafish Proteins/metabolism
- PubMed
- 29042681 Full text @ Sci. Rep.
Citation
Wang, J., Leng, X., Wang, G., Wan, X., Cao, H. (2017) The construction of intrahepatic cholangiocarcinoma model in zebrafish. Scientific Reports. 7:13419.
Abstract
Intrahepatic cholangiocarcinoma (ICC) is a highly malignant tumor, difficult to diagnose even at an early stage. In this study, we successfully constructed an nras 61K -induced ICC model in zebrafish. Transcriptome analysis and gene set enrichment analysis (GSEA) of liver samples of the ICC and WT (wild-type) zebrafish revealed that the genes differentially expressed between the two groups were mainly involved in focal adhesion, chemokine signaling and metabolic pathways. Analysis of DNA methylomes revealed that compared with WT samples, methylated genes in ICC samples were enriched in functions associated with cellular, single-organism and metabolic processes. In particular, our result discovered eleven potential biomarker genes of ICC which were conserved between zebrafish and humans. Moreover, three potential biomarker genes were hypomethylated in the tumorigenesis of ICC: ehf, epha4 and itgb6. In summary, our study provides a comprehensive analysis of molecular mechanisms accompanying the progressive nras 61K -induced ICC. This work indicates that our transgenic zebrafish could be a valuable model, not only for studying liver cancer, but also for exploring new therapeutic targets.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping